Vanda Pharmaceuticals Reports First Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 4.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.05 | 52 Week High | $18.00 | |||
| Open | $4.05 | 52 Week Low | $6.91 | |||
| Day High | $4.05 | P/E | N/A | |||
| Day Low | $4.05 | EPS | $-0.67 | |||
| Volume | 796 | |||||
